ICD-10-CM Billable Code

C81.95

Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb

Clinical Classification Guidelines

Medical Intelligence & Overview

Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune defense. When it affects the lymph nodes in the inguinal region (groin area) and the lower limbs, it can cause noticeable symptoms and require specific medical attention. The ICD-10 code C81.95 specifically refers to Hodgkin lymphoma that is diagnosed in these regions, although the exact site of origin may not be specified. This guide offers an overview of the causes, symptoms, diagnosis, and possible treatments related to this condition.

Causes & Symptoms

Clinical Causes: Genetic predisposition: A family history of Hodgkin lymphoma or other lymphatic cancers can increase risk. Infections: Certain viruses, such as Epstein-Barr virus (EBV), have been linked to the development of Hodgkin lymphoma. Immune system disorders: Conditions that weaken the immune response may increase susceptibility. Environmental exposures: Long-term exposure to certain chemicals or toxins may play a role in disease development. Age: Hodgkin lymphoma can occur at any age but is most common among young adults and those over 55.

Key Symptoms: Swelling of lymph nodes in the inguinal region (groin) and lower limbs, often painless and persistent. Enlargement of lymph nodes in other areas such as the neck or armpits. Persistent fatigue or tiredness. Unexplained weight loss over a short period. Fever that may come and go without an apparent cause. Night sweats, often severe enough to soak clothing or bedding. Itching (pruritus), which may be widespread or localized. Tenderness or discomfort in the affected lymph node areas. Possibly, symptoms related to pressure on nearby structures, such as pain or swelling in the lower limbs.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and diagnostic tests, including: - Physical examination to assess lymph node swelling. - Imaging studies such as CT scans or PET scans to evaluate the extent of disease. - Lymph node biopsy, where a small tissue sample is examined microscopically for characteristic features of Hodgkin lymphoma. - Blood tests to check overall health and organ function. - Additional testing as necessary to determine the disease stage and involvement of other lymphatic regions.

Treatment Protocols: The management of Hodgkin lymphoma often involves a multidisciplinary approach, tailored to the individual's stage and overall health. Common treatment options include: - Chemotherapy: Drugs administered to destroy cancer cells. - Radiation therapy: Targeted radiation may be used to eliminate localized disease. - Stem cell transplantation: In certain cases, especially if the disease recurs, this may be considered. - Clinical trials: Patients may have access to new therapies through research studies. - Supportive care: Addressing side effects, maintaining nutrition, and managing symptoms are integral parts of treatment. It’s important to consult healthcare professionals to determine the most appropriate course of action based on specific circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.95 a billable ICD-10 code?
Yes, C81.95 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.95?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference